USPTO Deadlines
Next Deadline
1006 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20220920)
Due Date
September 20, 2028
Grace Period Ends
March 20, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
40 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 7, 2025 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Mar 2, 2024 | CHLD | M | CHANGE OF OWNER RECEIVED FROM IB | Loading... |
| Nov 13, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Oct 25, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Oct 25, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 20, 2022 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Sep 20, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 20, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 24, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jul 5, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 5, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 29, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jun 29, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jun 15, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 31, 2022 | CREV | I | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | Loading... |
| May 2, 2022 | FINA | R | FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE | Loading... |
| Mar 29, 2022 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
| Mar 28, 2022 | ATRQ | I | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | Loading... |
| Feb 22, 2022 | CRTP | C | REG. CANCELLED - RESTORED TO PENDENCY | Loading... |
| Feb 22, 2022 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Feb 18, 2022 | RCII | I | REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED | Loading... |
| Feb 3, 2022 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Jan 31, 2022 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED | Loading... |
| Jan 4, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 14, 2021 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
| Oct 19, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 19, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 29, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 14, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 14, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 10, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 9, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 9, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 9, 2021 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Jul 9, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 9, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 9, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 6, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 4, 2021 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Jun 25, 2021 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Classification
International Classes
005